Literature DB >> 35948657

Maternal early-pregnancy body mass index-associated metabolomic component and mental and behavioral disorders in children.

Polina Girchenko1, Marius Lahti-Pulkkinen2,3,4, Jari Lipsanen2, Kati Heinonen2,5, Jari Lahti2, Ville Rantalainen2, Esa Hämäläinen6, Hannele Laivuori7,8,9,10, Pia M Villa11, Eero Kajantie12,13, Katri Räikkönen2.   

Abstract

Maternal pre-pregnancy obesity and/or higher body mass index (BMI) have been associated with neurodevelopmental and mental health adversities in children. While maternal metabolomic perturbations during pregnancy may underpin these associations, the existing evidence is limited to studying individual metabolites, not capturing metabolic variation specific to maternal BMI, and not accounting for the correlated nature of the metabolomic measures. By using multivariate supervised analytical methods, we first identified maternal early-pregnancy BMI-associated metabolomic component during pregnancy. We then examined whether this component was associated with mental and behavioral disorders in children, improved the prediction of the child outcomes over maternal BMI, and what proportion of the effect of maternal BMI on the child outcomes this component mediated. Early-pregnancy BMI of 425 mothers participating in the PREDO study was extracted from the national Medical Birth Register. During pregnancy, mothers donated up to three blood samples, from which a targeted panel of 68 metabolites were measured. Mental and behavioral disorders in children followed-up from birth until 8.4-12.8 years came from the Care Register for Health Care. Of the 68 metabolites averaged across the three sampling points, 43 associated significantly with maternal early-pregnancy BMI yielding a maternal early-pregnancy BMI-associated metabolomic component (total variance explained, 55.4%; predictive ability, 52.0%). This metabolomic component was significantly associated with higher hazard of any mental and behavioral disorder [HR 1.45, 95%CI(1.15, 1.84)] and relative risk of having a higher number of co-morbid disorders [RR 1.43, 95%CI(1.12, 1.69)] in children. It improved the goodness-of-model-fit over maternal BMI by 37.7-65.6%, and hence the predictive significance of the model, and mediated 60.8-75.8% of the effect of maternal BMI on the child outcomes. Maternal BMI-related metabolomic perturbations during pregnancy are associated with a higher risk of mental and behavioral disorders in children. These findings may allow identifying metabolomic targets for personalized interventions.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 35948657     DOI: 10.1038/s41380-022-01723-3

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


  35 in total

1.  Obstetric and Neonatal Risks Among Obese Women Without Chronic Disease.

Authors:  Sung Soo Kim; Yeyi Zhu; Katherine L Grantz; Stefanie N Hinkle; Zhen Chen; Maeve E Wallace; Melissa M Smarr; Nikira M Epps; Pauline Mendola
Journal:  Obstet Gynecol       Date:  2016-07       Impact factor: 7.661

Review 2.  Influence of maternal obesity on the long-term health of offspring.

Authors:  Keith M Godfrey; Rebecca M Reynolds; Susan L Prescott; Moffat Nyirenda; Vincent W V Jaddoe; Johan G Eriksson; Birit F P Broekman
Journal:  Lancet Diabetes Endocrinol       Date:  2016-10-12       Impact factor: 32.069

3.  Associations of Different Types of Maternal Diabetes and Body Mass Index With Offspring Psychiatric Disorders.

Authors:  Linghua Kong; Ida A K Nilsson; Kerstin Brismar; Mika Gissler; Catharina Lavebratt
Journal:  JAMA Netw Open       Date:  2020-02-05

Review 4.  Maternal Obesity as a Risk Factor for Brain Development and Mental Health in the Offspring.

Authors:  Francesca Cirulli; Chiara Musillo; Alessandra Berry
Journal:  Neuroscience       Date:  2020-02-05       Impact factor: 3.590

Review 5.  Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child.

Authors:  Patrick M Catalano; Kartik Shankar
Journal:  BMJ       Date:  2017-02-08

Review 6.  Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews.

Authors:  J Marchi; M Berg; A Dencker; E K Olander; C Begley
Journal:  Obes Rev       Date:  2015-05-28       Impact factor: 9.213

7.  Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis.

Authors:  C E Sanchez; C Barry; A Sabhlok; K Russell; A Majors; S H Kollins; B F Fuemmeler
Journal:  Obes Rev       Date:  2017-11-22       Impact factor: 9.213

Review 8.  Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis.

Authors:  Dagfinn Aune; Ola Didrik Saugstad; Tore Henriksen; Serena Tonstad
Journal:  JAMA       Date:  2014-04-16       Impact factor: 56.272

9.  Maternal obesity and long-term neuropsychiatric morbidity of the offspring.

Authors:  Zipora Feiga Neuhaus; Gil Gutvirtz; Gali Pariente; Tamar Wainstock; Daniella Landau; Eyal Sheiner
Journal:  Arch Gynecol Obstet       Date:  2020-01-22       Impact factor: 2.344

10.  Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts.

Authors:  S Santos; E Voerman; P Amiano; H Barros; L J Beilin; A Bergström; M-A Charles; L Chatzi; C Chevrier; G P Chrousos; E Corpeleijn; O Costa; N Costet; S Crozier; G Devereux; M Doyon; M Eggesbø; M P Fantini; S Farchi; F Forastiere; V Georgiu; K M Godfrey; D Gori; V Grote; W Hanke; I Hertz-Picciotto; B Heude; M-F Hivert; D Hryhorczuk; R-C Huang; H Inskip; A M Karvonen; L C Kenny; B Koletzko; L K Küpers; H Lagström; I Lehmann; P Magnus; R Majewska; J Mäkelä; Y Manios; F M McAuliffe; S W McDonald; J Mehegan; E Melén; M Mommers; C S Morgen; G Moschonis; D Murray; C Ní Chaoimh; E A Nohr; A-M Nybo Andersen; E Oken; Ajjm Oostvogels; A Pac; E Papadopoulou; J Pekkanen; C Pizzi; K Polanska; D Porta; L Richiardi; S L Rifas-Shiman; N Roeleveld; L Ronfani; A C Santos; M Standl; H Stigum; C Stoltenberg; E Thiering; C Thijs; M Torrent; S C Tough; T Trnovec; S Turner; Mmhj van Gelder; L van Rossem; A von Berg; M Vrijheid; Tgm Vrijkotte; J West; A H Wijga; J Wright; O Zvinchuk; Tia Sørensen; D A Lawlor; R Gaillard; Vwv Jaddoe
Journal:  BJOG       Date:  2019-03-20       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.